Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets
Yuezhen Liu,Bing Jiang,Yanqiang Li,Xiaoshou Zhang,Lijun Wang,Yasai Yao,Baohong Zhu,Hengwei Shi,Xiping Chai,Xingrong Hu,Bangneng Zhang,Hongzhuan Li
DOI: https://doi.org/10.1097/md.0000000000036467
IF: 1.6
2024-01-20
Medicine
Abstract:Osteosarcoma (OS) is the most common primary malignant bone tumor in adolescents and children. [ 1 ] According to research studies, 20,000 to 30,000 patients worldwide are afflicted with osteosarcoma each year. [ 2 ] Clinically, OS can be intervened by radiotherapy. Although this treatment is effective to some extent, and the 5-year survival rate of osteosarcoma patients can reach 60% to 70%, this survival rate accounts for only 20% for patients with metastatic OS, [ 3 ] of which the lungs account for 90% of metastatic sites and other bones account for 8% to 10%. [ 4 ] Meanwhile, radiation can also damage the normal tissue around the tumor, resulting in inevitable complications. In recent years, chemotherapeutic drugs for the treatment of OS can include methotrexate, doxorubicin, cisplatin, eflornithine and etoposide. Although these drugs have a certain significant effect on patients with OS, long-term use will lead to drug resistance in tumor cells. [ 5 ] In addition, radical resection and limb salvage surgery are more than 90% of surgical cases. Although surgery can significantly improve the patient's condition, the low number of cases makes it challenging to recruit sufficient populations to support high-quality studies, [ 6 ] and the survival rate of OS patients through amputation is only 20% to 30%. [ 7 ] Notably, OS patients also have a significant economic burden when faced with other complications. [ 8 ] Therefore, exploring an efficient and safe strategy to treat OS is still an important topic and hotspot in the field of current medicine.
medicine, general & internal